BIOMAT Database Logo BIOMAT Database Logo

Characterization of reverse transcriptase activity and susceptibility to other nucleosides of AZT-resistant variants of HIV-1. Results from the Canadian AZT Multicentre Study. 1990

M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Jewish General Hospital, Montreal, Canada.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D002170 Canada The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase

Related Publications

M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
July 1993, FEBS letters,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Vertical transmission of HIV-1 variants resistant to reverse transcriptase and protease inhibitors.
January 2001, Archives of internal medicine,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors.
February 2015, AIDS research and human retroviruses,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Interaction of tRNA-derivatives and oligonucleotide primers with AZT-resistant mutants of HIV-1 reverse transcriptase.
November 1998, Bioorganic & medicinal chemistry,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Mechanism by which phosphonoformic acid resistance mutations restore 3'-azido-3'-deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase.
March 2000, The Journal of biological chemistry,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.
August 1997, Nucleic acids research,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase.
May 1995, Journal of medicinal chemistry,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.
October 2003, The Journal of biological chemistry,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.
January 1992, Journal of enzyme inhibition,
M A Wainberg, and M Tremblay, and R Rooke, and N Blain, and H Soudeyns, and M A Parniak, and X J Yao, and X G Li, and M Fanning, and J S Montaner
HIV-1 clinical isolates with the E138A substitution in reverse transcriptase show full susceptibility to emtricitabine and other nucleoside reverse transcriptase inhibitors.
September 2014, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!